An exclusive program uniting the top 12% of U.S. MiSight day prescribers to advance myopia management strategies.

The US launch of a myopia control spectacle lens, research into modifiable myopia risk factors, and atropine developments ...

Submitted data were not enough to support the effectiveness of SYD-101 in children with myopia, according to the FDA. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) ...

Ray-Ban maker EssilorLuxottica is scheduled to report results for the third quarter on Thursday. Here is what you need to know: REVENUE FORECAST: The Franco-Italian eyewear group is expected to book ...

COLUMBIA — New Morning, a Columbia nonprofit dedicated to public education about and access to family planning services, and MUSC Health are joining forces to provide contraceptive care statewide. No ...

Prior to this approval, the only other device indicated for slowing pediatric myopia progression was a contact lens. The Food and Drug Administration (FDA) has cleared the Essilor Stellest eyeglass ...

Secretary of Transportation Sean Duffy is expanding the number of schools that can participate in a fast-tracked air traffic control training program, as the administration seeks more ways to address ...

Working with the Parkersburg Correctional Center with financing from a Litter Control Grant from the state Department of Environmental Protection, the city has removed more than 23,458 pounds of ...

ON WISN 12. IT’S A STAFFING CRISIS FUELING SAFETY CONCERNS FOR AIRLINE PASSENGERS. THERE ARE NOT ENOUGH AIR TRAFFIC CONTROL WORKERS RECENTLY TRAVELED TO ONE OF THE ONLY AIR TRAFFIC CONTROL PROGRAMS IN ...

In the late 1950s, the CIA was obsessed with mind control—what it was, how to weaponize it, and how to keep it out of Soviet hands. But instead of toiling in the lab to find the answers, the agency ...

Elevance Health and UC Irvine study underscores potential of digital health tools to reduce asthma burden across U.S. populations INDIANAPOLIS--(BUSINESS WIRE)--A groundbreaking clinical trial led by ...